查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018780

生物安全檢測產品與服務市場：2026-2032年全球市場預測，依產品、檢測方法、技術、最終用途及服務類型分類

Biological Safety Testing Products & Services Market by Product, Test, Technology, End Use, Service Mode - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，生物安全檢測產品和服務市場價值將達到 69.8 億美元，到 2026 年將成長至 77.8 億美元，到 2032 年將達到 149.8 億美元，複合年成長率為 11.51%。

主要市場統計數據
基準年 2025 69.8億美元
預計年份：2026年 77.8億美元
預測年份 2032 149.8億美元
複合年成長率 (%) 11.51%

全面概述現代生物安全檢測的優先事項以及影響實驗室和生產韌性的戰略促進因素。

生物安全檢測正逐漸成為科學研究、臨床和生產領域機構的核心策略。隨著監管要求日益嚴格，相關人員對產品完整性的審查也愈發嚴格，實驗室負責人和品管團隊必須部署能夠可靠檢測污染風險，並能無縫融入更快產品開發週期的檢測系統。同時，技術和分析技術的進步正在重新定義檢測的可能性，以實現更靈敏、自動化和高通量的檢測方法，從而減少停機時間並確保持續合規。

技術創新、更嚴格的監管和供應鏈重組如何影響生物安全檢測的營運模式？

生物安全檢測領域正經歷快速變革，這主要歸因於技術創新、數位融合以及監管機構對產品安全性的日益重視。新型分析平台和改進的檢測化學技術提高了靈敏度和特異性，重塑了檢測方法的選擇和驗證流程。同時，實驗室自動化和工作流程最佳化平台提高了處理能力和可重複性，減少了人為因素的影響，並加快了決策週期。

評估近期美國關稅變化對生物安全檢測供應鏈和籌資策略的營運和採購影響。

美國近期實施的關稅措施為從全球供應商採購設備、試劑和專用零件的企業帶來了新的挑戰。這些貿易干預措施提高了某些進口商品的接收成本，迫使採購者重新評估供應商選擇標準、庫存緩衝和總擁有成本 (TCO) 的計算，從而影響採購決策。從營運角度來看，這些成本壓力促使企業探索在地採購，並與供應商就價值工程解決方案展開更深入的對話。

高解析度細分分析揭示了產品、測試方法、技術、最終用途和服務模式的交匯領域，從而形成需求模式。

了解市場需要多角度的觀點，將技術要求與使用者需求結合。基於產品細分，市場被分為四大類：「儀器」、「試劑和試劑盒」、「服務和軟體」。儀器又細分為生物安全櫃、ELISA 儀器和 PCR 儀器等類別。試劑和試劑盒包括培養基、ELISA 試劑和試劑盒以及 PCR 試劑和試劑盒。服務包括校準服務、諮詢服務和驗證服務。軟體包括資料管理軟體和工作流程自動化軟體。這些產品細分揭示了資本投資、耗材成本和持續服務合約的集中方向，有助於確定哪些供應商的能力對不同的使用者群體最有價值。

對美洲、歐洲、中東和非洲以及亞太地區的需求促進因素、監管差異和供應狀況進行區域分析，以指南策略定位。

區域差異在決定生物安全檢測的優先順序方面起著至關重要的作用。在美洲，先進的製造地、嚴格的監管要求以及成熟的服務供應商生態系統共同推動了需求成長。這種環境鼓勵對自動化、驗證服務和資料管理平台進行投資，以支援合規性和規模化生產。同時，在歐洲、中東和非洲（EMEA）地區，監管協調的努力和各國不同的框架使得適應性和完善的文件記錄至關重要，當地的專業服務提供者通常與全球供應商合作，以提供符合合規性的解決方案。

對企業策略、夥伴關係以及產品/服務整合如何決定生物安全檢測領域的競爭優勢進行了深入的評估。

生物安全檢測生態系統中的主要企業透過整合技術深度、法規專業知識和廣泛的服務範圍來脫穎而出。一些公司專注於創新先進的計量儀器和耗材，大力投資於檢測性能和穩定性，以滿足受監管行業的需求。其他市場參與企業則優先考慮卓越的服務，提供校準、驗證和諮詢服務包，以降低客戶採用門檻並加快監管核准。越來越多的公司也專注於軟體和數據解決方案，使檢查室能夠整合測試數據、自動化工作流程並在檢查期間證明數據的完整性。

透過有系統地實施自動化、資料完整性實務和彈性籌資策略來加強試點專案的實用領導指南。

領導者應優先考慮那些既能提升短期營運效率又能促進持續能力建構的投資。關鍵措施包括加快採用快速自動化檢測方法，這些方法能夠在降低風險和縮短週期時間的同時，確保符合監管要求。對資料管理和工作流程自動化的配對投資將透過提高可追溯性、減少人為錯誤以及縮短品質和合規團隊的審核週期，進一步放大這些優勢。同時，加強與供應商的關係並採用多元化採購策略，可以降低貿易中斷帶來的風險，並保障關鍵試劑和組件供應鏈的持續性。

對技術和商業性見解所依據的多源研究途徑、驗證實踐和分析框架進行透明的解釋。

本分析結合了一手和二手研究，旨在全面掌握測試方法的技術細節以及影響採購和服務模式的商業性因素。一手資料包括對檢查室經理、品質專家、採購負責人和服務供應商的訪談，從中深入了解驗證挑戰、供應商動態和營運重點。二手資料包括公開的監管指南、技術白皮書、供應商資料和行業報告，這些資料提供了測試方法的性能特徵和技術比較資訊。

最終整合策略重點，強調對技術、驗證和供應彈性進行全面投資，以提高測試的可靠性。

總之，生物安全檢測領域瞬息萬變，各機構必須採取綜合方法，兼顧技術卓越、法規應對力、營運韌性。儀器、試劑和軟體的進步為提高檢測靈敏度和流程效率提供了重要機遇，但要實現這些目標，需要嚴謹的驗證，確保資料完整性，並符合監管要求。在採購和供應鏈趨勢不斷變化的背景下，積極主動地實現供應商多元化和服務夥伴關係，可以降低風險，並維持關鍵檢測能力的連續性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：生物安全檢測產品與服務市場：依產品類別分類

  • 裝置
    • 生物安全櫃
    • ELISA裝置
    • PCR裝置
  • 試劑和試劑盒
    • 培養基
    • ELISA試劑和試劑盒
    • PCR試劑和試劑盒
  • 服務
    • 校對服務
    • 諮詢服務
    • 驗證服務
  • 軟體
    • 資料管理軟體
    • 工作流程自動化軟體

第9章：依檢測類型分類的生物安全檢測產品與服務市場

  • 微生物附著量
    • 平板計數
    • 快速方法
  • 內毒素
    • LAL考試
    • rFC 測試
  • 微生物鑑定
    • MALDI-TOF
    • 基於PCR的
  • 無菌
    • 直接接種
    • 薄膜過濾

第10章：生物安全檢測產品與服務市場：依技術分類

  • 層析法
  • ELISA
  • 質譜分析
  • PCR

第11章：生物安全檢測產品與服務市場：依最終用途分類

  • 學術研究和調查
  • 生物技術
  • CRO
  • 食品/飲料
  • 醫院/診斷
  • 製藥

第12章：按服務類型分類的生物安全檢測產品與服務市場

  • 內部實施
  • 外包

第13章：生物安全偵測產品與服務市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：生物安全檢測產品與服務市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：生物安全檢測產品與服務市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國生物安全檢測產品與服務市場

第17章：中國生物安全檢測產品與服務市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Asahi Kasei Corporation
  • Avance Biosciences Inc.
  • BBF Sterilisationsservice GmbH
  • BSL Bioservice Scientific Laboratories Munich GmbH
  • Charles River Laboratories International, Inc.
  • Creative Biogene
  • Eurofins Scientific SE
  • Labquality Oy
  • Lonza Group AG
  • Merck KGaA
  • North American Science Associates, Inc.
  • NuAire, Inc.
  • Pace Analytical Services, LLC
  • Samsung Biologics
  • Sartorius AG
  • SGS Societe Generale de Surveillance SA
  • Thermo Fisher Scientific Inc.
  • Toyobo Co., Ltd.
  • UL LLC
  • ViruSure GmbH
  • WuXi Biologics Co., Ltd.
Product Code: MRR-A866040826BE

The Biological Safety Testing Products & Services Market was valued at USD 6.98 billion in 2025 and is projected to grow to USD 7.78 billion in 2026, with a CAGR of 11.51%, reaching USD 14.98 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.98 billion
Estimated Year [2026] USD 7.78 billion
Forecast Year [2032] USD 14.98 billion
CAGR (%) 11.51%

Comprehensive orientation to contemporary biological safety testing priorities and strategic enablers shaping laboratory and manufacturing resilience

Biological safety testing has emerged as a strategic backbone for organizations operating in research, clinical and manufacturing environments. As regulatory expectations tighten and stakeholder scrutiny of product integrity increases, laboratory leaders and quality teams are under pressure to adopt testing regimens that reliably detect contamination risks while integrating seamlessly into faster product development cycles. In parallel, advances in technology and analytics are redefining what is possible, enabling more sensitive, automated, and high-throughput approaches that reduce downtime and support consistent compliance.

This report synthesizes current industry dynamics as they pertain to instruments, consumables, services, and software frameworks that collectively constitute biological safety testing capabilities. It also examines the implications for laboratories and manufacturers as they navigate a shifting regulatory landscape, evolving supply chains, and new commercial models for testing services. The objective is to provide strategic readers with a clear line of sight into the operational levers that can improve safety outcomes, lower risk exposure, and enhance the resilience of testing programs.

Throughout this document, attention is given to both the technical considerations-such as method selection, validation rigor, and data integrity-and the organizational enablers including workforce skills, vendor partnerships, and digital integration. This integrated view supports executives and technical leaders in prioritizing investments that deliver measurable improvements in testing reliability and regulatory confidence.

How converging technological innovation, regulatory tightening, and supply chain reorientation are reshaping biological safety testing operational models

The landscape of biological safety testing is undergoing rapid transformation driven by converging forces: technological innovation, digital integration, and heightened regulatory focus on product safety. New analytical platforms and enhanced assay chemistries are raising the bar for sensitivity and specificity, which in turn reshapes method selection and validation pathways. Simultaneously, laboratory automation and workflow orchestration platforms are enabling higher throughput and reproducibility, reducing manual variability and accelerating decision cycles.

Regulatory authorities are recalibrating expectations around data integrity, traceability, and risk-based testing strategies, prompting organizations to adopt more robust quality systems and stronger documentation practices. As regulators emphasize lifecycle assurance, firms must invest in controls that demonstrate consistent performance across manufacturing scales and supply chain partners. This regulatory tightening favors solutions that provide auditable data trails and interoperability with laboratory information management systems.

Supply chain dynamics are also shifting, influencing procurement and risk management strategies for critical test consumables and instruments. Organizations are responding by diversifying supplier bases, pursuing strategic long-term agreements, and embracing service models that mitigate inventory and calibration burden. Taken together, these trends are prompting laboratories to rethink their operating models, prioritize digital and technical upgrades, and cultivate partnerships that accelerate safe, compliant, and efficient testing outcomes.

Evaluating the operational and procurement consequences of recent United States tariff changes on biological safety testing supply chains and sourcing strategies

Recent tariff measures implemented in the United States have introduced a new layer of complexity for organizations that source instruments, reagents, and specialized components from global suppliers. These trade interventions have influenced procurement decisions by increasing landed costs for certain imported goods, which in turn has prompted buyers to re-evaluate vendor selection criteria, inventory buffers, and total cost of ownership calculations. From an operational standpoint, such cost pressures have encouraged firms to explore local sourcing alternatives and increase dialogue with suppliers around value-engineered solutions.

In practice, the impact of tariff changes extends beyond immediate cost adjustments. Organizations have adapted by revisiting contractual terms, incorporating flexibility in supply agreements, and accelerating qualification of alternative suppliers to reduce exposure. Procurement teams are employing scenario-based analyses to quantify the operational implications of ongoing tariff volatility, while quality leaders continue to emphasize equivalency and validation pathways for alternative products. These adaptive behaviors support continuity of testing operations and maintain compliance while organizations navigate a more uncertain trade environment.

Moreover, the tariff environment has reinforced the appeal of service-based models, where calibration, validation, and other technical functions can be outsourced to geographically diversified partners. By shifting certain operational responsibilities to service providers, organizations can reduce capital outlays and benefit from more predictable operating costs. In summary, recent tariff developments have catalyzed strategic shifts in sourcing philosophy, inventory management, and partnership design across the biological safety testing ecosystem.

High-resolution segmentation analysis revealing where product, test method, technology, end use, and service mode converge to shape demand patterns

Understanding the market requires a multi-dimensional view that aligns technical requirements with user needs. Based on product segmentation, the market is studied across Instruments, Reagents & Kits, Services, and Software; Instruments are further examined through categories including Biosafety Cabinets, ELISA Instruments, and PCR Instruments; Reagents & Kits include Culture Media, ELISA Reagents & Kits, and PCR Reagents & Kits; Services encompass Calibration Services, Consulting Services, and Validation Services; and Software incorporates Data Management Software and Workflow Automation Software. These product distinctions reveal where capital expenditure, consumable spend, and recurring service commitments concentrate, and they help identify which vendor capabilities are most valuable to different user cohorts.

Examining the market by test reveals differentiated operational and methodological imperatives. Based on test segmentation, the market is studied across Bioburden, Endotoxin, Microbial Identification, and Sterility; Bioburden testing is further distinguished by Plate Count and Rapid Methods; Endotoxin testing is categorized into LAL Test and rFC Test; Microbial Identification covers MALDI-TOF and PCRBased approaches; and Sterility testing includes Direct Inoculation and Membrane Filtration. These distinctions clarify where investments in rapid methods and high-sensitivity platforms yield the greatest operational benefit and where traditional methods remain indispensable for regulatory acceptance.

The technology dimension further illuminates the technical trade-offs organizations face. Based on technology segmentation, the market is studied across Chromatography, ELISA, Mass Spectrometry, and PCR, each offering distinct performance characteristics, throughput profiles, and validation complexities. In turn, the end use segmentation highlights who demands these solutions and how procurement priorities differ across application contexts. Based on end use segmentation, the market is studied across Academic & Research, Biotechnology, CRO, Food & Beverage, Hospitals & Diagnostics, and Pharmaceutical. These end users prioritize different combinations of throughput, sensitivity, regulatory readiness, and total cost.

Service mode adds a final layer of operational differentiation. Based on service mode segmentation, the market is studied across In House and Outsourced. Organizations electing in-house delivery often do so for greater control and ownership of methods, while those opting to outsource prioritize operational flexibility and access to specialized capabilities. Synthesizing across these segmentation lenses provides a roadmap for product development, commercial positioning, and customer support models that align technical capabilities with the nuanced needs of varied end users.

Region-specific analysis of demand drivers, regulatory variances, and supply realities across Americas, EMEA, and APAC that inform strategic positioning

Regional variation plays a central role in shaping priorities for biological safety testing. In the Americas, demand is driven by a combination of advanced manufacturing footprints, stringent regulatory expectations, and a mature service provider ecosystem. This environment encourages investments in automation, validation services, and data management platforms that support compliance and scale. Meanwhile, in Europe, Middle East & Africa, regulatory harmonization efforts and diverse national frameworks create a landscape where adaptability and strong documentation practices are critical, and where specialized local providers often partner with global vendors to deliver compliant solutions.

The Asia-Pacific region presents a different set of dynamics characterized by rapid capacity expansion in manufacturing and research, a growing middle-market for clinical diagnostics, and varying regulatory maturity across countries. Organizations operating in Asia-Pacific frequently prioritize cost-efficiency alongside scalable testing workflows, and they often pursue hybrid models that blend local sourcing with global technology partnerships. Across regions, supply chain considerations, tariff impacts, and access to trained personnel shape the tactical choices that laboratories and manufacturers make when selecting instruments, reagents, and service models.

Taken together, these geographic perspectives underscore the importance of tailoring commercial and technical approaches for regional realities. Companies that align product portfolios and support models with regional regulatory and operational requirements are better positioned to capture demand and build resilient partnerships.

Insightful assessment of how corporate strategies, partnerships, and product-service integration define competitive advantage in biological safety testing

Leading companies in the biological safety testing ecosystem differentiate through a combination of technical depth, regulatory expertise, and service breadth. Some firms concentrate on advanced instrumentation and consumable innovation, investing heavily in assay performance and ruggedization to meet the needs of regulated industries. Other market participants emphasize service excellence, offering calibration, validation, and consulting packages that reduce adoption friction and accelerate regulatory acceptance for customers. There is also a growing cohort that focuses on software and data solutions, enabling laboratories to unify testing data, automate workflows, and demonstrate data integrity during inspections.

Strategic partnerships and channel models are common, as companies seek to extend their reach and localize support services. Distribution networks, certification programs, and training offerings are key enablers of customer success, particularly in regions with emerging regulatory frameworks. Mergers and acquisitions have historically been a mechanism to acquire complementary capabilities, accelerate time to market for integrated solutions, and consolidate technical expertise. Overall, successful firms balance product innovation with strong service delivery and scalable commercial models that address the operational realities faced by laboratory and manufacturing customers.

Practical leadership guidance to fortify testing programs through methodical adoption of automation, data integrity practices, and resilient sourcing strategies

Leaders should prioritize investments that deliver both short-term operational improvements and durable capability upgrades. Key actions include accelerating the adoption of rapid and automated testing modalities where they demonstrably reduce risk or cycle time while maintaining regulatory defensibility. Complementary investments in data management and workflow automation will amplify these benefits by improving traceability, reducing manual errors, and enabling faster review cycles for quality and compliance teams. In parallel, stronger supplier relationship management and multi-sourcing strategies will reduce vulnerability to trade disruptions and support continuity of critical reagent and component supply.

Operationally, it is important to develop clear validation roadmaps that expedite qualification of alternative products and methods when procurement dynamics change. Investing in cross-functional training enhances resilience by broadening internal capability to adapt methods and interpret complex data. Finally, consider service partnerships for non-core functions such as specialized calibration and validation to free internal teams to focus on strategic priorities. These approaches collectively reduce risk, enhance agility, and create measurable improvements in testing throughput and compliance readiness.

Transparent explanation of the multi-source research approach, validation practices, and analytical frameworks underpinning the technical and commercial findings

This analysis draws on a mix of primary and secondary research tailored to capture both the technical nuances of testing methods and the commercial considerations that shape procurement and service models. Primary inputs include interviews with laboratory leaders, quality specialists, procurement professionals, and service providers, eliciting insights on validation challenges, supplier dynamics, and operational priorities. Secondary inputs encompass published regulatory guidelines, technical whitepapers, vendor documentation, and industry reports that inform method performance characteristics and technology comparisons.

Analytically, findings were synthesized using a cross-sectional framework that maps product and technology capabilities to test requirements and end user needs. Validation methods included triangulation across interviews and documented specifications, and where appropriate, scenario analysis to assess how tariff and supply chain shifts might influence sourcing decisions. Quality controls for the research process included expert review cycles and sensitivity checks to ensure interpretations are robust and actionable for decision-makers operating in regulated environments.

Final synthesis of strategic priorities emphasizing integrated investments in technology, validation, and supply resilience to elevate testing reliability

In closing, the evolving landscape of biological safety testing requires organizations to adopt a holistic approach that balances technical excellence, regulatory readiness, and operational resilience. Advances in instruments, reagents, and software offer substantial opportunities to improve detection sensitivity and process efficiency, but realizing these gains depends on careful validation, data integrity practices, and alignment with regulatory expectations. As procurement and supply chain dynamics shift, a proactive approach to supplier diversification and service partnerships can mitigate risk and preserve continuity of critical testing capabilities.

Ultimately, leaders who combine targeted technology investments with stronger data governance, robust validation roadmaps, and adaptive sourcing strategies will be best positioned to maintain compliance while accelerating product and process timelines. The resulting capability improvements not only reduce safety risk but also enable organizations to scale more efficiently and respond to regulatory inquiry with confidence. These integrated steps form the foundation for a resilient and future-ready approach to biological safety testing.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biological Safety Testing Products & Services Market, by Product

  • 8.1. Instruments
    • 8.1.1. Biosafety Cabinets
    • 8.1.2. ELISA Instruments
    • 8.1.3. PCR Instruments
  • 8.2. Reagents & Kits
    • 8.2.1. Culture Media
    • 8.2.2. ELISA Reagents & Kits
    • 8.2.3. PCR Reagents & Kits
  • 8.3. Services
    • 8.3.1. Calibration Services
    • 8.3.2. Consulting Services
    • 8.3.3. Validation Services
  • 8.4. Software
    • 8.4.1. Data Management Software
    • 8.4.2. Workflow Automation Software

9. Biological Safety Testing Products & Services Market, by Test

  • 9.1. Bioburden
    • 9.1.1. Plate Count
    • 9.1.2. Rapid Methods
  • 9.2. Endotoxin
    • 9.2.1. LAL Test
    • 9.2.2. rFC Test
  • 9.3. Microbial Identification
    • 9.3.1. MALDI-TOF
    • 9.3.2. PCRBased
  • 9.4. Sterility
    • 9.4.1. Direct Inoculation
    • 9.4.2. Membrane Filtration

10. Biological Safety Testing Products & Services Market, by Technology

  • 10.1. Chromatography
  • 10.2. ELISA
  • 10.3. Mass Spectrometry
  • 10.4. PCR

11. Biological Safety Testing Products & Services Market, by End Use

  • 11.1. Academic & Research
  • 11.2. Biotechnology
  • 11.3. CRO
  • 11.4. Food & Beverage
  • 11.5. Hospitals & Diagnostics
  • 11.6. Pharmaceutical

12. Biological Safety Testing Products & Services Market, by Service Mode

  • 12.1. In House
  • 12.2. Outsourced

13. Biological Safety Testing Products & Services Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Biological Safety Testing Products & Services Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Biological Safety Testing Products & Services Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Biological Safety Testing Products & Services Market

17. China Biological Safety Testing Products & Services Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Asahi Kasei Corporation
  • 18.6. Avance Biosciences Inc.
  • 18.7. BBF Sterilisationsservice GmbH
  • 18.8. BSL Bioservice Scientific Laboratories Munich GmbH
  • 18.9. Charles River Laboratories International, Inc.
  • 18.10. Creative Biogene
  • 18.11. Eurofins Scientific SE
  • 18.12. Labquality Oy
  • 18.13. Lonza Group AG
  • 18.14. Merck KGaA
  • 18.15. North American Science Associates, Inc.
  • 18.16. NuAire, Inc.
  • 18.17. Pace Analytical Services, LLC
  • 18.18. Samsung Biologics
  • 18.19. Sartorius AG
  • 18.20. SGS Societe Generale de Surveillance SA
  • 18.21. Thermo Fisher Scientific Inc.
  • 18.22. Toyobo Co., Ltd.
  • 18.23. UL LLC
  • 18.24. ViruSure GmbH
  • 18.25. WuXi Biologics Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOSAFETY CABINETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOSAFETY CABINETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CULTURE MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CULTURE MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CALIBRATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CALIBRATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CALIBRATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY VALIDATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY VALIDATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY VALIDATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY WORKFLOW AUTOMATION SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY WORKFLOW AUTOMATION SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY WORKFLOW AUTOMATION SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PLATE COUNT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PLATE COUNT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PLATE COUNT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY RAPID METHODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY RAPID METHODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY RAPID METHODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY LAL TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY LAL TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY LAL TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY RFC TEST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY RFC TEST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY RFC TEST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MALDI-TOF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MALDI-TOF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MALDI-TOF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCRBASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCRBASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCRBASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY DIRECT INOCULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY DIRECT INOCULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY DIRECT INOCULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MEMBRANE FILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MEMBRANE FILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MEMBRANE FILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CRO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CRO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY CRO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY FOOD & BEVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY FOOD & BEVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY HOSPITALS & DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY HOSPITALS & DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY HOSPITALS & DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY IN HOUSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY IN HOUSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY IN HOUSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY OUTSOURCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY OUTSOURCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 260. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 261. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 262. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 263. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KIT